Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morgenstern, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgenstern, L. B.
Neurology 2001;57:S45-S47
© 2001 American Academy of Neurology


Articles

What have we learned from clinical neuroprotective trials?

Lewis B. Morgenstern, MD

From the Department of Neurology, University of Texas Medical School, Houston, Texas.

Address correspondence and reprint requests to Dr. Lewis B. Morgenstern, Department of Neurology, University of Texas Medical School, 6431 Fannin 7.044, Houston TX 77030. Email: Lewis.Morgenstern{at}uth.tmc.edu

Although no neuroprotective agent is yet available for acute stroke patients, the information we have gleaned from clinical neuroprotective trials is incredibly valuable. We know that these agents are biologically active, potentially safe, and likely to have a primary role in the acute treatment of the stroke patient. The ischemic cascade has been attacked from a myriad of directions, and we now appreciate some of the advantages and limitations of preclinical models. We can use this knowledge to design more effective trials in the future.




This article has been cited by other articles:


Home page
RadiologyHome page
Y.-J. Liu, C.-Y. Chen, H.-W. Chung, I.-J. Huang, C.-S. Lee, S.-C. Chin, and M. Liou
Neuronal Damage after Ischemic Injury in the Middle Cerebral Arterial Territory: Deep Watershed versus Territorial Infarction at MR Perfusion and Spectroscopic Imaging
Radiology, November 1, 2003; 229(2): 366 - 374.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. L. Tirschwell, W.T. Longstreth Jr, K. J. Becker, R. E. Gammans Sr, L. A. Sabounjian, S. Hamilton, and L. B. Morgenstern
Shortening the NIH Stroke Scale for Use in the Prehospital Setting
Stroke, December 1, 2002; 33(12): 2801 - 2806.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. J. Gladstone, S. E. Black, and A. M. Hakim
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Stroke, August 1, 2002; 33(8): 2123 - 2136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.